综合医院对惊恐障碍的诊断识别及干预研究

摘要

目的 探讨综合医院对惊恐障碍的诊断识别及药物干预联合心理治疗的效果和安全性.方法 选择我院2012年6月-2015年12月收治的惊恐障碍84例为研究对象,按照随机数字表法分为观察组和对照组,每组各42例.两组均予安非他酮缓释片治疗,观察组在此基础上予心理治疗.两组均治疗8周,分别于治疗前及治疗后第1、2、4、8周末进行惊恐障碍相关症状量表(PASS)评分、汉密尔顿抑郁量表(HAMD)评分及汉密尔顿焦虑量表(HAMA)评分以评定治疗效果,采用不良反应量表(TESS)评定药物不良反应.结果 与本组治疗前比较,两组治疗后第1、2、4、8周PASS、HAMD和HAMA评分均降低,差异有统计学意义(P0.05).结论 综合医院对惊恐障碍识别率低,安非他酮缓释片联合心理治疗临床效果好,安全性高.%Objective To investigate diagnosed identification for panic disorder in general hospitals and the effect and safety of drug intervention combined with psychotherapy.Methods A total of 84 patients with panic disorder admitted during June 2012 and December 2015 were divided into observation group (n=42) and control group (n=42) according to random digits table method.All patients were treated with Bupropion Sustained-release Tablets, and observation group received psychological treatment on the basis of treatment.Two groups were treated for 8 weeks.Panic disorder associated symptoms scale (PASS) score, Hamilton depression scale (HAMD) score and Hamilton anxiety scale (HAMA) score were detected before and in 1st, 2nd, 4th and 8th weeks after treatment to evaluate the therapeutic effects.Treatment emergent symptom scale (TESS) was used to evaluate adverse drug reactions.Results PASS, HAMD and HAMA scores were significantly decreased in 1st, 2nd, 4th and 8th weeks after treatment compared with those before treatment in two groups (P0.05).Conclusion Diagnosed identification rate of panic disorder in general hospitals is low, and Bupropion Sustained-release Tablets combined with psychotherapy can achieve good effect and safety.